Viewing Study NCT06008756


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-01 @ 10:27 PM
Study NCT ID: NCT06008756
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2023-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module